«Achondroplasia

Below is an extended Achondroplasia patents listing. Click here to return to the Achondroplasia main in depth entry.

Patents :
US Patent No.	Title
7078059	Treatment of bone diseases
7192583	Methods for modulating bone mineralization
7198790	Growth differentiation factor-5
7202025	Control of gene expression
7208274	Rapid analysis of variations in a genome
7217699	Compositions comprising genome segments and methods of using the same
7220406	Method for promoting bone formation
7226902	Ligands for TGF-beta binding proteins and uses thereof
7235241	Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
7235634	2786, a novel human aminopeptidase
7250405	Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy
7189507	Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
7166461	Polynucleotides encoding a super-active porcine growth hormone releasing hormone analog
7160916	Method of increasing bone density or treating osteoporosis
7090869	Method for producing preparation containing bioactive substance
7094565	21612, novel human dehydrogenases
7098015	27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
7108984	Methods of identifying modulators of the FGF receptor
7108991	Human orphan G protein-coupled receptors
7119190	Endogenous and non-endogenous versions of human G protein-coupled receptors
7122550	Protein kinase inhibitors
7129072	Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor
7135311	Means for detecting and treating pathologies linked to FGFR3
7135320	Adaptor protein FRS2 and related products and methods
7252974	Human growth gene and short stature gene region
7253266	Polypeptides of FGF-CX
7348142	Cancer diagnostic panel
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7381409	Antibodies specific for sclerostin and methods of screening and use therefor
7385034	Complementary DNAs encoding proteins with signal peptides
7385036	Human tango 509 polypeptides
7402434	Splice choice antagonists as therapeutic agents
7410777	Non-endogenous, constitutively activated human G protein-coupled receptors
7411051	Antibodies to HDPPA04 polypeptide
7414109	FIAT nucleic acids and proteins and uses thereof
7332277	Methods for detection of genetic disorders
7329529	Ubiqutin proteases
7301016	Human transferase family members and uses thereof
7259179	Kinase inhibitors
7273724	Polypeptide-human actin-binding protein 54 and a polynucleotide encoding the same
7276481	Method and composition for treatment of skeletal dysplasias
7288392	Human protein kinases and uses therefor
7288406	Active variants of FGF with improved specificity
7291461	Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7291483	FGF-CX polynucleotide sequences and methods of producing same
7297492	LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
7297493	Fibroblast growth factor receptor activating gene 1 and related compositions and methods
7297774	Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
7425531	Bone polypeptide-1

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.